Key Dates

Related Announcements

PAR-19-287 - Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to revise the last application due date for PAR-19-287 "Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)" for approximately two months.

In Part 1 of this FOA, under Key Dates, the last application due date of November 15, 2021, has now been revised and the new application due date is January 28, 2022.

I. Part 1 Key Dates in PAR-19-287 Currently Reads:

Application Due Date(s)

July 15, 2019, November 15, 2019, July 10, 2020, November 17, 2020, July 9, 2021, November 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Not Applicable

Scientific Merit Review

October-November 2019, February-March 2020, October-November 2020, February-March 2021, October-November 2021, February-March 2022

Advisory Council Review

January 2020, May 2020, January 2021, May 2021, January 2022, May 2022

Earliest Start Date

April 2020

Expiration Date

November 16, 2021

II. Part 1 Key Dates in PAR-19-287 Modified (by this Notice) to Read (in italics):

Application Due Date(s)

July 15, 2019, November 15, 2019, July 10, 2020, November 17, 2020, July 9, 2021, January 28, 2022, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Not Applicable

Scientific Merit Review

October-November 2019, February-March 2020, October-November 2020, February-March 2021, October-November 2021, February-March 2022

Advisory Council Review

January 2020, May 2020, January 2021, May 2021, January 2022, May 2022

Earliest Start Date

April 2020

Expiration Date

January 29, 2022

NOTE: All other aspects of this funding opportunity announcement (PAR-19-287) remain unchanged.

Inquiries

Please direct all inquiries to:

Hannah Dueck, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5751
Email: [email protected]